PubRank

P J van Diest

Author PubWeight™ 211.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001 4.27
2 Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat 2012 3.99
3 Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001 3.94
4 Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000 3.20
5 Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 2005 2.70
6 Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993 2.60
7 Doxorubicin gradients in human breast cancer. Clin Cancer Res 1999 2.36
8 Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 2001 2.33
9 Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005 2.10
10 Radioactive seed localization for non-palpable breast cancer. Br J Surg 2013 2.07
11 Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol 2000 2.04
12 Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998 2.02
13 Relationships between vascularization and proliferation in invasive breast cancer. J Pathol 1999 1.90
14 Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 1997 1.82
15 [The sentinel node procedure: standard intervention for surgical treatment of breast cancer]. Ned Tijdschr Geneeskd 1998 1.76
16 Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 1995 1.75
17 Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol 1998 1.62
18 Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology 2003 1.59
19 Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol 1996 1.58
20 Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol 1998 1.58
21 The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 2007 1.57
22 Comparative genomic hybridisation. Mol Pathol 1999 1.56
23 Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998 1.54
24 Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol 1998 1.49
25 Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer 2003 1.48
26 Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005 1.47
27 In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol 2008 1.42
28 Impactitis: new cures for an old disease. J Clin Pathol 2001 1.42
29 Histopathology of fibroadenoma of the breast. Am J Clin Pathol 2001 1.41
30 DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol 2007 1.40
31 Quality control methods for data entry in pathology using a computerized data management system based on an extended data dictionary. Hum Pathol 1992 1.38
32 Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001 1.34
33 Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000 1.34
34 Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol 1994 1.31
35 Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 1999 1.28
36 Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 2000 1.27
37 Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 2001 1.26
38 Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997 1.25
39 Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 1999 1.25
40 The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer 2001 1.25
41 Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol 2004 1.25
42 Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 2006 1.24
43 Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer 1998 1.23
44 Molecular imaging of breast cancer. Breast 2009 1.22
45 Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res 2000 1.21
46 Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol 2009 1.20
47 Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene 2006 1.17
48 Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001 1.16
49 Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000 1.16
50 Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol 2011 1.14
51 Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol 1995 1.13
52 Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol 2008 1.12
53 Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol 2011 1.12
54 Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000 1.10
55 Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg Br 1999 1.10
56 Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 1997 1.10
57 The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals. Plast Reconstr Surg 2001 1.10
58 Microarray techniques in pathology: tool or toy? Mol Pathol 2000 1.09
59 The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands. Pathol Res Pract 1989 1.09
60 Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry. J Clin Pathol 1996 1.08
61 Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. Cell Oncol 2005 1.08
62 A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing. J Clin Pathol 2005 1.08
63 Epigenetics in ovarian cancer. Methods Mol Biol 2012 1.07
64 Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer. J Clin Pathol 2002 1.07
65 Counting of apoptotic cells: a methodological study in invasive breast cancer. Clin Mol Pathol 1996 1.06
66 Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer. Am J Obstet Gynecol 1996 1.06
67 Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. Mol Pathol 1999 1.06
68 Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas. J Clin Pathol 2006 1.05
69 Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest 1990 1.05
70 Counting mitoses by image processing in Feulgen stained breast cancer sections: the influence of resolution. Cytometry 1997 1.04
71 Tubal ligation and risk of ovarian cancer. Lancet 2001 1.04
72 mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy? J Clin Pathol 2008 1.03
73 Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. Ann Oncol 2013 1.03
74 Balance of cell proliferation and apoptosis in breast carcinogenesis. Breast Cancer Res Treat 1999 1.02
75 Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins. J Surg Oncol 1999 1.01
76 Improving early breast cancer detection: focus on methylation. Ann Oncol 2010 1.01
77 Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. Am J Surg Pathol 2001 1.01
78 Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 2004 1.00
79 Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tube. Histopathology 2001 0.99
80 Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma. J Clin Pathol 1996 0.99
81 Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas. Oncogene 2006 0.99
82 Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 1999 0.98
83 Sentinel node detection in cervical cancer. Obstet Gynecol 2000 0.98
84 Neuroendocrine carcinoma of the sphenoid sinus: a case report. Rhinology 2001 0.97
85 Expression of HIF-1alpha in human tumours. J Clin Pathol 2005 0.97
86 Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 1999 0.97
87 Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Lab Invest 1991 0.97
88 Nuclear cytometric changes in breast carcinogenesis. J Pathol 2001 0.96
89 Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol 2007 0.95
90 Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast. Int J Cancer 1999 0.94
91 Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J Pathol 1998 0.94
92 Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles. Cancer Gene Ther 2008 0.94
93 Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 2000 0.94
94 Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation. Anal Quant Cytol Histol 1993 0.91
95 No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res 2001 0.91
96 Origins of ... image analysis in clinical pathology. J Clin Pathol 1997 0.90
97 Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 2006 0.89
98 Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers. J Clin Pathol 2009 0.89
99 Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets. Endocr Relat Cancer 2012 0.89
100 Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men. Am J Surg Pathol 2000 0.89
101 Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. Hum Pathol 1998 0.89
102 Ectopic lobular breast cancer on the anterior chest wall: a rare entity. J Clin Pathol 2007 0.89
103 Survival analysis in familial ovarian cancer, a case control study. Eur J Obstet Gynecol Reprod Biol 2001 0.89
104 Accuracy of contrast-enhanced breast ultrasound for pre-operative tumor size assessment in patients diagnosed with invasive ductal carcinoma of the breast. Cancer Imaging 2007 0.89
105 Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients. Recent Results Cancer Res 2000 0.89
106 Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J Cancer 2000 0.88
107 Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol 2007 0.88
108 Radiofrequency ablation for breast cancer: a review of the literature. Eur J Surg Oncol 2007 0.87
109 Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2004 0.87
110 Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis. Cancer 1993 0.87
111 Radical surgical treatment in craniofacial osteosarcoma gives excellent survival. A retrospective cohort study of 14 patients. Eur J Cancer B Oral Oncol 1994 0.87
112 Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer 2007 0.86
113 Oxytocin: bringing magic into nipple aspiration. Ann Oncol 2007 0.86
114 HIF-1A gene mutations associated with higher microvessel density in endometrial carcinomas. Histopathology 2008 0.86
115 Characterization of ex vivo healthy human axillary lymph nodes with high resolution 7 Tesla MRI. Eur Radiol 2010 0.85
116 At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients. Breast Cancer Res Treat 1995 0.85
117 Mammary fibroadenoma in a male-to-female transsexual. Histopathology 1999 0.85
118 Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation. Eur J Cancer 2007 0.85
119 Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma. J Pathol 2008 0.85
120 Progressive derailment of cell cycle regulators in endometrial carcinogenesis. J Clin Pathol 2007 0.85
121 Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis. Dis Esophagus 2009 0.85
122 Differences between hereditary and sporadic ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999 0.84
123 Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers. Ann Oncol 2007 0.84
124 Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP). Int J Cancer 1997 0.84
125 Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium. Hum Pathol 1995 0.84
126 VEGF-D and HIF-1alpha in breast cancer. J Clin Pathol 2005 0.84
127 DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Hum Pathol 1995 0.84
128 Primary non-Hodgkin's lymphoma of the salivary glands. An analysis of 22 cases. J Oral Pathol Med 1996 0.84
129 Rapid and reliable assessment of volume percentage of epithelium in borderline and invasive ovarian tumors. Anal Quant Cytol Histol 1998 0.84
130 Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Am J Clin Pathol 2000 0.84
131 Comparative genomic hybridisation as a supportive tool in diagnostic pathology. J Clin Pathol 2003 0.84
132 Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer. J Clin Pathol 2004 0.83
133 Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Lab Invest 2001 0.83
134 Better retrieval of lymph nodes in colorectal resection specimens by pathologists' assistants. J Clin Pathol 2012 0.83
135 Long-term survival of T1 and T2 lymph node-negative breast cancer patients according to Mitotic Activity Index: a population-based study. Int J Cancer 2006 0.83
136 Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer. Biotech Histochem 2006 0.83
137 Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer. Oncologist 1999 0.83
138 Prognostic value of morphometry in patients with normal breast tissue or usual ductal hyperplasia of the breast. Int J Cancer 2001 0.83
139 Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules. Clin Endocrinol (Oxf) 2007 0.83
140 [18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor. J Clin Endocrinol Metab 2004 0.83
141 Malignancy-associated changes in breast tissue detected by image cytometry. Anal Cell Pathol 2000 0.82
142 Migration of silicone through the fibrous capsules of mammary prostheses. Ann Plast Surg 1997 0.82
143 Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material. Anal Cell Pathol 1995 0.82
144 Experience with a dynamic inexpensive video-conferencing system for frozen section telepathology. Anal Cell Pathol 2000 0.82
145 Text processing by digital voice recognition. Anal Quant Cytol Histol 1996 0.82
146 Multiplex ligation-dependent probe amplification to detect HER2 amplification in breast cancer: new insights in optimal cut-off value. Cell Oncol 2010 0.81
147 Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project. Mod Pathol 1997 0.81
148 The Multi-Center Morphometric Mammary Carcinoma Project (MMMCP) in The Netherlands: value of morphometrically assessed proliferation and differentiation. J Cell Biochem Suppl 1993 0.81
149 p16 is consistently expressed in endometrial tubal metaplasia. Cell Oncol 2007 0.81
150 Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 2001 0.81
151 The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study. Ann Oncol 2013 0.80
152 Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division? Clin Exp Immunol 2008 0.80
153 Re: Chu et al "Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?". Ann Surg 2000 0.80
154 Syntactic structure analysis of the arrangement of nuclei in dysplastic epithelium of colorectal adenomatous polyps. Anal Quant Cytol Histol 1992 0.80
155 Mammary development and breast cancer: the role of stem cells. Curr Mol Med 2011 0.80
156 DDX3 has divergent roles in head and neck squamous cell carcinomas in smoking versus non-smoking patients. Oral Dis 2015 0.80
157 HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study. Histopathology 2007 0.80
158 Three-dimensional confocal laser scanning DNA ploidy cytometry in thick histological sections. J Pathol 1996 0.80
159 The female corpus spongiosum revisited. Acta Obstet Gynecol Scand 1995 0.80
160 Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy. Breast Cancer Res Treat 2011 0.80
161 Sparing a testis during vaginoplasty in male-to-female transsexuals: does it benefit our patients? Plast Reconstr Surg 2001 0.80
162 Keeping osteocytes alive: a comparison of drilling and hammering k-wires into bone. J Hand Surg Eur Vol 2008 0.79
163 Expression of growth factors, growth factor receptors and apoptosis related proteins in invasive breast cancer: relation to apoptotic rate. Breast Cancer Res Treat 2001 0.79
164 Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group. Cancer 1996 0.79
165 Molecular diagnosis of head and neck cancer. Recent Results Cancer Res 2000 0.79
166 Rapid stereology based quantitative immunohistochemistry of dendritic cells in lymph nodes: a methodological study. Anal Cell Pathol 2001 0.79
167 Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. Mol Pathol 2002 0.79
168 HER-family gene amplification and expression in resected pancreatic cancer. Eur J Surg Oncol 2009 0.79
169 Prognostic value of morphometric features and the callender classification in uveal melanomas. Ophthalmology 1996 0.79
170 The new millennium: time for a change! J Clin Pathol 2000 0.79
171 Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study. J Clin Pathol 2013 0.79
172 Predicting nonsentinel lymph node involvement in stage I/II melanoma. Ann Surg Oncol 2003 0.78
173 Relevant impact of central pathology review on nodal classification in individual breast cancer patients. Ann Oncol 2012 0.78
174 Fluorescent stains for quantification of DNA by confocal laser scanning microscopy in 3-D. Biotech Histochem 2008 0.78
175 Models predicting non-sentinel node involvement also predict for regional recurrence in breast cancer patients without axillary treatment. Eur J Surg Oncol 2013 0.78
176 Trends in breast cancer aggressiveness before the introduction of mass screening in southeastern Netherlands 1975-1989. Breast Cancer Res Treat 2002 0.78
177 Borderline ovarian tumors. Am J Surg Pathol 1998 0.78
178 How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma. J Clin Pathol 2003 0.78
179 Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. Mol Pathol 1998 0.78
180 The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma. Pathobiology 2015 0.77
181 A morphometric filter improves the diagnostic value of morphometric analyses of frozen histopathological sections from mammary tumours. Anal Cell Pathol 1992 0.77
182 CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment. Breast Cancer Res Treat 2013 0.76
183 Comparison of five cell cycle analysis models applied to 1414 flow cytometric DNA histograms of fresh frozen breast cancer. Cytometry 1997 0.76
184 A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers. J Neurooncol 2000 0.76
185 Data processing and analysis in the Multicenter Morphometric Mammary Carcinoma Project (MMMCP). Pathol Res Pract 1989 0.76
186 [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development]. Ned Tijdschr Geneeskd 2007 0.76
187 A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature. Int J Gynecol Cancer 2007 0.76
188 Lack of cyclin D1 overexpression in gastric carcinogenesis. Histopathology 2000 0.75
189 A novel rapid and sensitive BRCA1/2 mutation detection method based on pooled DGGE and targeted sequencing. J Clin Pathol 2007 0.75
190 Syntactic structure analysis in uveal melanomas. Br J Ophthalmol 1994 0.75
191 Prognostic value of morphometry in breast cancer. J Clin Pathol 1991 0.75
192 Cervical cancer. J Clin Pathol 2002 0.75
193 Tumor cell dyscohesion in carcinoma of the breast. Am J Clin Pathol 1998 0.75
194 A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumour. J Clin Pathol 2004 0.75
195 Electronic publishing and internet learning. J Clin Pathol 2002 0.75
196 Sentinel-node biopsy in breast cancer. Lancet 2001 0.75
197 On "Familial intestinal polyposis" by C E Dukes. J Clin Pathol 2000 0.75
198 [Summary of the guideline 'Sentinel Lymph Node Biopsy for Breast Cancer']. Ned Tijdschr Geneeskd 2001 0.75
199 Fibroadenoma of the breast with positive pet-scan. JBR-BTR 2012 0.75
200 Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers. Biotech Histochem 2010 0.75
201 Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases. Ann Oncol 2012 0.75
202 Results of a study made during the European course on the application of quantitative pathology in clinical oncology. Anal Cell Pathol 1992 0.75
203 Reliable DNA histogram interpretation. Number of nuclei requiring measurement with flow cytometry. Anal Quant Cytol Histol 1997 0.75
204 Volume-weighted mean nuclear volume and nuclear area in advanced ovarian carcinoma. An investigation of sampling methods, sample size and reproducibility. Anal Quant Cytol Histol 1995 0.75
205 [Patient with Peutz-Jeghers syndrome and liver metastases from an unknown primary tumor]. Ned Tijdschr Geneeskd 2000 0.75
206 Colpectomy after vaginoplasty in transsexuals. Obstet Gynecol 2000 0.75
207 Prognostic value of morphometry in acute lymphoblastic leukemia of childhood. Anal Quant Cytol Histol 1992 0.75
208 Influence of boundary effects on minimum spanning tree features. A computer simulation. Anal Quant Cytol Histol 1996 0.75
209 The utility of histological examination of tissue removed during elective joint replacement. A preliminary assessment. J Bone Joint Surg Am 1999 0.75
210 Intratumor heterogeneity of morphometric and stereologic variables in primary ovarian tumors and their omental metastatic deposits. Anal Quant Cytol Histol 1997 0.75
211 Minimum spanning tree analysis in advanced ovarian carcinoma. An investigation of sampling methods, reproducibility and correlation with histologic grade. Anal Quant Cytol Histol 1997 0.75